Assessment of quality-of-life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study
Growth Hormone & IGF Research Sep 14, 2017
Ishii H, et al. - The physicians applied the newly developed Adult Hypopituitarism Questionnaire (AHQ) to evaluate the quality of life (QOL) in Japanese adult growth hormone deficiency (AGHD) patients receiving recombinant growth hormone (GH). They reported that four-year GH treatment in Japanese AGHD patients causes sustained improvement in QOL.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
